ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Launches $18M Program to Encourage Produce Consumption

July 17, 1992

In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division

January 5, 1996

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003